Joanna Pikiel Selected Research

Joanna Pikiel Research Topics

Disease

9	Breast Neoplasms (Breast Cancer) 04/2022 - 01/2003
8	Disease Progression 11/2022 - 01/2011
5	Neoplasms (Cancer) 11/2022 - 01/2014
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 08/2014
3	Adenocarcinoma 02/2022 - 01/2014
2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2017
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2018 - 01/2003
2	Neutropenia 01/2017 - 08/2014
2	Febrile Neutropenia 01/2017 - 08/2014
2	Hypertension (High Blood Pressure) 08/2014 - 01/2014
2	Pain (Aches) 03/2014 - 01/2003
2	Prostatic Neoplasms (Prostate Cancer) 03/2014 - 01/2003
1	Endometrial Neoplasms (Endometrial Cancer) 11/2023
1	Skin Neoplasms (Skin Cancer) 10/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2022
1	Heart Diseases (Heart Disease) 08/2021
1	Hypophysitis 01/2017
1	Colitis 01/2017
1	Fatigue 08/2014
1	Stomach Neoplasms (Stomach Cancer) 01/2014
1	Cardiotoxicity 01/2011
1	Multiple Myeloma 01/2003
1	Hypercalcemia (Milk Alkali Syndrome) 01/2003
1	Spontaneous Fractures (Pathological Fracture) 01/2003
1	Fever (Fevers) 01/2003
1	Spinal Cord Compression 01/2003
1	Neoplasm Metastasis (Metastasis) 01/2003

Drug/Important Bio-Agent (IBA)

6	Trastuzumab (Herceptin)FDA Link 08/2021 - 01/2011
5	PlatinumIBA 10/2022 - 01/2014
5	RamucirumabIBA 02/2022 - 01/2014
4	Docetaxel (Taxotere)FDA Link 10/2017 - 03/2014
3	Biosimilar PharmaceuticalsIBA 08/2021 - 01/2017
3	Capecitabine (Xeloda)FDA Link 12/2015 - 01/2011
3	Lapatinib (GW572016)FDA Link 12/2015 - 01/2011
2	dostarlimabIBA 11/2023 - 11/2022
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2022 - 01/2019
2	CT-P6IBA 08/2021 - 01/2017
2	IpilimumabIBA 01/2020 - 01/2017
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 10/2017 - 01/2014
2	Monoclonal AntibodiesIBA 10/2017 - 01/2014
2	AnthracyclinesIBA 01/2017 - 01/2011
2	human ERBB2 proteinIBA 12/2015 - 02/2014
2	Vinorelbine (Navelbine)FDA LinkGeneric 12/2015 - 02/2014
1	Tumor Biomarkers (Tumor Markers)IBA 11/2023
1	Biomarkers (Surrogate Marker)IBA 11/2023
1	B7-H1 AntigenIBA 11/2022
1	LigandsIBA 10/2022
1	cemiplimabIBA 10/2022
1	Progesterone Receptors (Progesterone Receptor)IBA 04/2022
1	Steroid Receptors (Steroid Receptor)IBA 04/2022
1	Epidermal Growth Factor (EGF)IBA 08/2021
1	MicroRNAs (MicroRNA)IBA 08/2020
1	Estrogens (Estrogen)FDA Link 08/2020
1	Hormones (Hormone)IBA 08/2020
1	Progesterone FDA LinkGeneric 08/2020
1	PF-05280014IBA 01/2019
1	cabozantinibIBA 01/2018
1	Everolimus FDA Link 01/2018
1	Bevacizumab (Avastin)FDA Link 10/2017
1	Immunoglobulins (Immunoglobulin)IBA 10/2017
1	Immune Checkpoint InhibitorsIBA 01/2017
1	Alanine Transaminase (SGPT)IBA 01/2017
1	SodiumIBA 03/2014
1	Proteins (Proteins, Gene)FDA Link 03/2014
1	LY 2181308IBA 03/2014
1	Prednisone (Sone)FDA LinkGeneric 03/2014
1	Antisense OligonucleotidesIBA 03/2014
1	Prostate-Specific Antigen (Semenogelase)IBA 03/2014
1	SurvivinIBA 03/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014
1	VimentinIBA 01/2014
1	Keratin-5 (Keratin 5)IBA 01/2014
1	Phenobarbital (Luminal)FDA Link 01/2014
1	Estrogen ReceptorsIBA 01/2014
1	Taxoids (Taxanes)IBA 01/2011
1	Clodronic Acid (Clodronate)IBA 01/2003
1	Analgesics (Analgesic Drugs)IBA 01/2003
1	Pamidronate (Aredia)FDA LinkGeneric 01/2003

Therapy/Procedure

7	Therapeutics 01/2018 - 01/2003
3	Drug Therapy (Chemotherapy) 10/2022 - 01/2014
2	Neoadjuvant Therapy 08/2021 - 01/2017
1	Intravenous Infusions 01/2017
1	Castration 03/2014
1	Duration of Therapy 01/2011
1	Radiotherapy 01/2003